Boston Partners’s Vital Farms VITL Stock Holding History

Boston Partners’s Portfolio VITL Stock Details VITL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-102,861	Closed	-$1.45M	–	852
2026 Q1	$1.45M	Buy	+102,861	New	+$2.43M	﹤0.01%	605

Other funds holding VITL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Boston Partners's VITL Position: Q2 2026 in Review

Boston Partners sold out of Vital Farms (VITL) in Q2 2026, closing a stake of 102,861 shares — an estimated $1.45M sold.

Boston Partners first reported a position in VITL in Q1 2026 and held it in 1 quarter. The position peaked at $1.45M in Q1 2026. 226 funds tracked by Wall St. Rank hold VITL as of Q2 2026.

Boston Partners reported no remaining Vital Farms position as of Q2 2026 after selling out during the quarter.
Boston Partners sold 102,861 Vital Farms shares in Q2 2026, an estimated $1.45M.
Boston Partners first reported a position in Vital Farms in Q1 2026 and held it in 1 quarter.
Boston Partners's Vital Farms position peaked at $1.45M in Q1 2026.
226 funds tracked by Wall St. Rank held Vital Farms as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.